| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 298.19B | 300.61B | 333.99B | 334.50B | 271.18B | 225.12B |
| Gross Profit | 44.37B | 42.43B | 45.88B | 44.62B | 31.06B | 26.80B |
| EBITDA | 23.78B | 22.06B | 17.26B | 21.61B | 15.19B | 14.02B |
| Net Income | 6.67B | 6.39B | 4.68B | 6.32B | 386.00M | 578.00M |
Balance Sheet | ||||||
| Total Assets | 268.60B | 281.75B | 298.29B | 292.32B | 282.19B | 264.67B |
| Cash, Cash Equivalents and Short-Term Investments | 26.20B | 27.47B | 25.01B | 23.74B | 21.04B | 24.48B |
| Total Debt | 63.83B | 68.79B | 74.98B | 83.92B | 86.43B | 81.67B |
| Total Liabilities | 135.13B | 145.03B | 157.30B | 170.89B | 168.49B | 156.28B |
| Stockholders Equity | 132.09B | 135.28B | 139.68B | 120.27B | 112.66B | 107.43B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.49B | 12.98B | 6.47B | -14.01B | -5.90B |
| Operating Cash Flow | 0.00 | 15.39B | 22.32B | 15.06B | -5.53B | 5.73B |
| Investing Cash Flow | 0.00 | -1.97B | -9.40B | -8.36B | -2.61B | -8.93B |
| Financing Cash Flow | 0.00 | -10.83B | -12.58B | -4.68B | 3.53B | 3.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥222.91B | 6.43 | 13.11% | 2.87% | 7.46% | 144.90% | |
75 Outperform | ¥214.74B | 14.77 | 7.50% | 5.39% | -1.82% | 23.07% | |
74 Outperform | ¥556.57B | 11.33 | ― | 2.60% | 1.02% | -2.46% | |
71 Outperform | ¥68.51B | 3.21 | ― | 3.66% | -1.11% | 162.30% | |
71 Outperform | ¥278.62B | -8.32 | ― | 1.93% | -1.60% | -71.42% | |
66 Neutral | ¥594.33B | 43.48 | 3.35% | 3.18% | 2.15% | -6.81% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |